Cspc Zhongqi Pharmaceutical Technology Co., Ltd.
Clinical trials sponsored by Cspc Zhongqi Pharmaceutical Technology Co., Ltd., explained in plain language.
-
New hope for advanced liver cancer patients: experimental combo therapy enters human trials
Disease control Not yet recruitingThis study tests a new treatment for people with advanced liver cancer whose first treatment stopped working. The treatment delivers a chemotherapy drug directly to the liver's blood supply, combined with other medications given through the body. About 116 adults aged 18 to 75 wi…
Phase: PHASE1, PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New Weight-Loss shot enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests a single dose of an investigational injection called SYH2082 in 44 healthy adults who are overweight or obese. The main goal is to check if the drug is safe and tolerable, not to treat or cure obesity. Participants will be randomly assigned to receive…
Phase: PHASE1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New hope for kids with rare MMA: B12 shot trial launches
Disease control Not yet recruitingThis study tests a vitamin B12 injection (hydroxocobalamin) in 20 children aged 6 months to 18 years with a rare genetic condition called methylmalonic acidemia (MMA) with high homocysteine. The goal is to see if the injection can normalize acid levels in the blood or urine and i…
Phase: PHASE3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC